top of page
national-cancer-institute-kWAPbD_zaEU-unsplash.jpg

Solutions

Driven by the goal of a healthier future, we push the boundaries of innovation.

Every discovery is a step toward accessible, transformative healthcare for everyone, today and for generations ahead.

Treatment Solution

Our MCT4 Inhibitor/F25 program represents a significant advancement in cancer research. By leveraging groundbreaking technology, we have engineered a program that redefines the standards of precision and safety in cancer treatment. It's pharmaceutical innovation reimagined.

national-cancer-institute-gyGyIEeikSw-unsplash.jpg
pexels-tara-winstead-7722541.jpg

Research Pipeline

At FlyNew Bio Inc., we hold a range of patents in both the U.S. and China that safeguard our advanced formulations, optimized manufacturing processes, and novel clinical applications. 

bottom of page